Trinity Biotech PLC reports results for the quarter ended in June - Earnings Summary

Trinity Biotech

03/10/2023 15:46

* Trinity Biotech PLC  TRIB.OQ  reported a quarterly
adjusted loss
of 15 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 9 cents per
share.
    * Revenue fell 24.7% to $13.90 million from a year ago;
analysts
expected $13.50 million. 
    * Trinity Biotech PLC's reported EPS for the quarter was a
loss
of 15 cents​.
    * The mean earnings estimate of analysts had fallen by
about 50%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Trinity Biotech PLC shares had fallen by 4.8% this
quarter and
lost 29.3% so far this year.
    * Wall Street's median 12-month price target for Trinity
Biotech
PLC is $4.00 

This summary was machine generated from LSEG Refinitiv data
October 3 at 02:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.09          -0.15          Missed
 Mar. 31 2023      -0.06          -0.15          Missed
 Dec. 31 2022      -0.06          -0.26          Missed
 Sep. 30 2022      -0.04          -0.23          Missed